Can a heart drug help during big belly surgeries? small study tests feasibility
NCT ID NCT07000994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether giving the heart medication dobutamine during major abdominal surgery is practical. Researchers aimed to give dobutamine for more than 70% of the surgery time in at least 80% of patients. The study enrolled 100 adults undergoing planned major abdominal surgery. The main goal was to see if the approach is feasible, not to measure patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dobutamine
- What this could lead to
- If successful, this could show that giving dobutamine during major abdominal surgery is practical, paving the way for larger studies on whether it helps prevent heart complications.
- What could go wrong
- This is a small pilot study focused on feasibility, not on patient outcomes. It may not show any clear benefit, and results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAOPERATIVE MYOCARDIAL DEPRESSION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Center Hamburg-Eppendorf
Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany